|
Volumn 3, Issue 5, 2001, Pages 387-390
|
Juvenile systemic scleroderma.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
PENICILLAMINE;
ADOLESCENT;
AGE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HOSPITALIZATION;
HUMAN;
INCIDENCE;
MALE;
METHODOLOGY;
PRESCHOOL CHILD;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
SYSTEMIC SCLEROSIS;
TREATMENT OUTCOME;
ADOLESCENT;
AGE FACTORS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
MALE;
PENICILLAMINE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SCLERODERMA, SYSTEMIC;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 0035486712
PISSN: 15233774
EISSN: None
Source Type: Journal
DOI: 10.1007/s11926-996-0008-4 Document Type: Review |
Times cited : (9)
|
References (34)
|